Côte d'Ivoire vs Malawi: Population requiring preventive chemotherapy for schistosomiasis
Côte d'Ivoire
8.30 million
in 2024
Malawi
10.17 million
in 2024
Côte d'Ivoire rank
10th
Malawi rank
8th
Population requiring preventive chemotherapy for schistosomiasis over time
- Côte d'Ivoire
- Malawi
How they compare
Malawi currently reports 10.17 million against 8.30 million in Côte d'Ivoire, a difference of 1.87 million.
That makes Malawi's figure about 1.2 times Côte d'Ivoire's.
Across all 15 years both countries report, Malawi has been ahead every year.
Côte d'Ivoire ranks 10th and Malawi ranks 8th of 52 countries.
Malawi has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.22 million | 7.42 million | 3.20 million | Malawi |
| 2020s | 6.94 million | 9.45 million | 2.51 million | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Côte d'Ivoire or Malawi?
- Malawi, at 10.17 million against 8.30 million in Côte d'Ivoire as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Côte d'Ivoire and Malawi?
- 1.87 million, with Malawi ahead.
- How many years of comparable data are there for Côte d'Ivoire and Malawi?
- 15 years are reported by both, from 2010 to 2024.
- How do Côte d'Ivoire and Malawi rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Côte d'Ivoire ranks 10th and Malawi ranks 8th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.